ARPA-H announces $139M initiative to transform behavioral health with first research teams named
Summary
ARPA-H (Advanced Research Projects Agency for Health) named its first research teams in a $139 million initiative to transform behavioral health, funding novel approaches to treating depression, PTSD, addiction, and other psychiatric conditions through high-risk, high-reward research programs. The initiative includes funding for non-pharmacological neuromodulation approaches, AI-driven psychiatric diagnostics, and digital therapeutics — positioning ARPA-H as a significant new funding source for neurotech companies developing psychiatric indications.
Why it matters
ARPA-H funding behavioral health specifically represents a shift from DARPA's historical defense-focused neurotechnology investment toward civilian health applications. $139M from a high-risk tolerance funder like ARPA-H will support the kinds of bold bets that NIH's conservative peer review process typically rejects — potentially funding the next generation of psychiatric neurostimulation approaches that commercial VCs consider too early-stage.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial